Latest Asx News

Boab Metals reveals a significant A$25 million capital cost reduction and a six-month faster construction timeline for its Sorby Hills Lead-Silver Project, bolstered by tender results and secured financing.

St Barbara Limited has completed a compelling restart study for its Touquoy gold project in Nova Scotia, outlining a low-capital, near-term operation with robust economics and a positive permitting outlook.

Assetora Limited has received a statutory demand for nearly $1 million from Specialised Investment and Lending Corporation, which it is vigorously disputing and legally challenging.

St Barbara Limited has locked in A$470 million in funding through strategic partnerships with Lingbao Gold Group and Kumul Mineral Holdings, fully financing the Simberi Gold Project expansion and accelerating its development timeline.

St Barbara Limited has agreed to sell a 20% interest in its Simberi Gold Project to Papua New Guinea’s Kumul Mineral Holdings for A$100 million, forming a strategic joint venture that aligns with PNG’s resource ownership goals.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Kingfisher Mining has completed its strategic acquisition of a diverse NSW copper-gold-silver-lead-zinc portfolio and is mobilizing drilling at the Copper Blow project in Broken Hill.

Janus Electric Holdings announces the resignation of CEO Ian Campbell, with interim leadership appointed as the company searches for a successor.

Greenwing Resources has amended its San Jorge Lithium Brine Project payment schedule, deferring two instalments to 2027 with added fees and options, while appointing Peter Wright as Managing Director with a new incentive package.

CVC Limited has issued $75 million in redeemable, unsecured notes set to trade on the ASX from December 11, offering investors an attractive 8.2% interest rate starting March 2026.

Frontier Digital Ventures is narrowing its focus to core classifieds, cutting loss-making units and revising FY25 earnings guidance to reflect a significant net loss. The company also reveals a potentially dilutive employee share plan in its Latin America subsidiary.

InhaleRx advances its clinical pipeline with a new oral treatment for resistant depression and plans a strategic rebrand to Nexalis Therapeutics, signaling a broader focus beyond inhaled therapies.